SERA 241115 2.50P (SERA241115P2500) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

SERA241115P2500

Watchlist

0.00
0.000.00%

15min DelayClose Nov 15 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
PR NewswireNov 15 08:30 ET
Have Sera Prognostics Insiders Been Selling Stock?
Simply Wall StNov 15 06:56 ET
TD Cowen Maintains Sera Prognostics(SERA.US) With Buy Rating
Moomoo NewsNov 8 17:31 ET · Ratings
TD Cowen Reaffirms Their Buy Rating on Sera Prognostics (SERA)
TipRanksNov 8 16:55 ET
Sera Prognostics (NASDAQ:SERA) Is In A Strong Position To Grow Its Business
Yahoo FinanceNov 8 05:30 ET
Sera Prognostics Faces Business Continuity Risks Amid Data Dependency
TipRanksNov 8 01:01 ET

Comments

Meltyy

Jan 4 01:15

$XBI: Biotech Sector's Potential Outperformance in 2024, Especially Pre-Election Volatility in 1H

$SPDR S&P Biotech ETF (XBI.US)$
The biotech sector faced challenges in the previous year, mainly attributed to high inflation and interest rates, particularly impacting small-cap biotech firms in the difficult fundraising environment of summer 2023.
As a consequence, numerous companies experienced a significant drop in their market caps, with some even falling below the 100 million mark, a rarity...